Implicity
Implicity Raises $40M Growth Equity for AI Cardiac Monitoring
Implicity announced $40M in Growth Equity financing on September 9, 2026. Implicity raised a $40 million growth equity round led by IRIS, alongside Five Arrows, to support its growth in the US and further AI investment.
Round details
The financing includes backing from IRIS, Five Arrows. The company did not publish a valuation with the announcement.
- Round: Growth Equity
- Capital announced: $40M
- Headquarters: Cambridge, MA and Paris, France
How the company plans to use the capital
Implicity said the round will fund commercial hiring in the US and development of US-specific features. It will also support continued investment in its AI and innovation roadmap, including the next generation of heart failure prediction algorithms.
Why this matters for GTM teams
IRIS led the round with Five Arrows participating. Implicity said it serves more than 250 medical centers and monitors more than 120,000 patients daily across the US, France and Germany.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Implicity growth equity announcement.
Company Info
Investors (2)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started